Ascendis Pharma A/S
ASND201.600USD
-2.110-1.04%
Cierre 10/31, 16:00（ET）Cotizaciones retrasadas 15 min
12.33BCap. mercado
PérdidaP/E TTM
Más Datos de Ascendis Pharma A/S Compañía
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Información de Ascendis Pharma A/S
Símbolo de cotizaciónASND
Nombre de la empresaAscendis Pharma A/S
Fecha de salida a bolsaJan 28, 2015
Director ejecutivoMr. Jan Moller Mikkelsen
Número de empleados- -
Tipo de seguridadDepository Receipt
Fin del año fiscalJan 28
DirecciónTuborg Boulevard 12
CiudadHELLERUP
Bolsa de valoresNASDAQ Global Select Consolidated
PaísDenmark
Código postal2900
Teléfono4570222244
Sitio Webhttps://ascendispharma.dk/
Símbolo de cotizaciónASND
Fecha de salida a bolsaJan 28, 2015
Director ejecutivoMr. Jan Moller Mikkelsen
Ejecutivos de Ascendis Pharma A/S
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
--
Mr. Donovan (Jay) Wu
Mr. Donovan (Jay) Wu
Executive Vice President, U.S. President
Executive Vice President, U.S. President
--
--
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Commercial sale of products
153.66M
97.23%
Rendering of services
3.57M
2.26%
License
812.00K
0.51%
Por regiónUSD
Nombre
Ganancia
Proporción
North America
108.45M
68.62%
Europe
27.89M
17.65%
Rest of world
21.70M
13.73%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Commercial sale of products
153.66M
97.23%
Rendering of services
3.57M
2.26%
License
812.00K
0.51%
Estadísticas de accionistas
Actualizado: dom., 12 de oct
Actualizado: dom., 12 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
RA Capital Management, LP
16.88%
Westfield Capital Management Company, L.P.
8.95%
Avoro Capital Advisors LLC
8.18%
Janus Henderson Investors
7.27%
Fidelity Management & Research Company LLC
6.86%
Otro
51.87%
Accionistas
Accionistas
Proporción
RA Capital Management, LP
16.88%
Westfield Capital Management Company, L.P.
8.95%
Avoro Capital Advisors LLC
8.18%
Janus Henderson Investors
7.27%
Fidelity Management & Research Company LLC
6.86%
Otro
51.87%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
41.98%
Investment Advisor
36.23%
Venture Capital
17.21%
Hedge Fund
6.13%
Private Equity
1.86%
Research Firm
1.70%
Individual Investor
0.77%
Pension Fund
0.32%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
509
64.52M
105.91%
-6.64M
2025Q2
502
70.53M
116.83%
-1.34M
2025Q1
513
68.89M
114.10%
-3.55M
2024Q4
488
67.37M
111.00%
-7.76M
2024Q3
475
65.25M
107.66%
-6.23M
2024Q2
459
63.44M
108.94%
-9.21M
2024Q1
453
63.54M
109.13%
-8.68M
2023Q4
430
62.90M
109.00%
-9.55M
2023Q3
414
62.85M
109.61%
-11.90M
2023Q2
426
63.03M
109.93%
-13.27M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
RA Capital Management, LP
10.28M
16.88%
--
--
Jun 30, 2025
Westfield Capital Management Company, L.P.
5.45M
8.95%
-27.86K
-0.51%
Jun 30, 2025
Avoro Capital Advisors LLC
4.98M
8.18%
-238.00K
-4.56%
Jun 30, 2025
Janus Henderson Investors
4.43M
7.27%
-59.16K
-1.32%
Jun 30, 2025
Fidelity Management & Research Company LLC
4.18M
6.86%
-125.41K
-2.91%
Jun 30, 2025
Artisan Partners Limited Partnership
3.99M
6.55%
-266.20K
-6.25%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
3.58M
5.88%
+529.72K
+17.35%
Jun 30, 2025
Capital International Investors
3.05M
5%
+172.14K
+5.99%
Jun 30, 2025
MFS Investment Management
1.90M
3.11%
+23.62K
+1.26%
Jun 30, 2025
T. Rowe Price Associates, Inc.
1.88M
3.08%
-380.61K
-16.87%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
Harbor Health Care ETF
16.34%
AdvisorShares Dorsey Wright ADR ETF
2.66%
American Century Focused Dynamic Growth ETF
2.5%
Virtus LifeSci Biotech Products ETF
1.89%
Tema Heart & Health ETF
1.51%
ProShares Ultra Nasdaq Biotechnology
1.2%
Invesco Nasdaq Biotechnology ETF
1.2%
Main Thematic Innovation ETF
1.07%
Putnam Sustainable Future ETF
1.03%
JPMorgan Healthcare Leaders ETF
0.76%
Ver más
Harbor Health Care ETF
Proporción16.34%
AdvisorShares Dorsey Wright ADR ETF
Proporción2.66%
American Century Focused Dynamic Growth ETF
Proporción2.5%
Virtus LifeSci Biotech Products ETF
Proporción1.89%
Tema Heart & Health ETF
Proporción1.51%
ProShares Ultra Nasdaq Biotechnology
Proporción1.2%
Invesco Nasdaq Biotechnology ETF
Proporción1.2%
Main Thematic Innovation ETF
Proporción1.07%
Putnam Sustainable Future ETF
Proporción1.03%
JPMorgan Healthcare Leaders ETF
Proporción0.76%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
